![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
Agents find waning value in the purchase of portal leads: Intel
Nearly 70 percent of agents who have purchased portal leads in the past say they no longer buy them, citing "time and money" needed for maximum ROI, according to the latest Intel Index polling data.
Nearly 70 percent of agents who have purchased portal leads in the past say they no longer buy them, citing "time and money" needed for maximum ROI, according to the latest Intel Index polling data.
